In vitro assays highlighted the greater effectiveness of RSV/DXT loaded EGF LPNs in decreasing the viability of tumor cells (HCC827 and NCIH2135) in comparison to RSV/DXT loaded LPNs, thus confirming the usefulness of including the targeting moiety EGF in the NP. The gene discussed is EGF; the disease is neoplasm.